Results 151 to 160 of about 10,789 (224)

Assessment of Azathioprine-Associated Lymphopenia Incidence Rates in Polish Children with Inflammatory Bowel Disease and Autoimmune Hepatitis: A Retrospective Study. [PDF]

Children (Basel)
Bąk-Drabik K, Kaput A, Jarzumbek A, Górowska-Kowolik K, Szymlak A, Krzywicka A, Adamczyk P, Kwiecień J.   +7 more
europepmc   +1 more source

Managing inflammatory bowel disease in patients receiving cancer-associated chemotherapy and beyond. [PDF]

Ann Gastroenterol
Ryan-Fisher C, Thorarensen S, Paladiya R, Vaziri H.   +3 more
europepmc   +1 more source

Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. [PDF]

Genes (Basel)
Pau A, Galliano I, Ponte A, Clemente A, Dini M, Calvi C, Montanari P, Pizzol A, Gambarino S, Calvo PL, Bergallo M.   +10 more
europepmc   +1 more source

Pharmacokinetics of 6-thioguanine nucleotide and 6-methyl-mercaptopurine in a case of inadvertent combination therapy of azathioprine with allopurinol [PDF]

, 2012
Alves, Atecla N. L.,, Chocair, Pedro R., Duley, John A., Fortini, Alexandre S., Mendes, Maria E., Nahas, William C., Pacheco-Neto, Maurílio, Sumita, Nairo M., Torres, Larissa H. L.   +8 more
core  

Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population. [PDF]

J Crohns Colitis
Everhov ÅH, Askling J, Söderling J, Halfvarson J, Eriksson J, Smedby KE, Ludvigsson JF, Sørensen HT, Olén O.   +8 more
europepmc   +1 more source

The fate of thiopurine metabolites after switching to low-dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis. [PDF]

Br J Clin Pharmacol
Bayoumy AB, D'Agnolo HMA, de Boer NKH, Mulder CJJ, Derijks LJJ.   +4 more
europepmc   +1 more source

Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS. [PDF]

Clin Pharmacol Ther
Bidoli C, Yang W, Karol SE, Lucafò M, Stocco G, Yang JJ.   +5 more
europepmc   +1 more source

Analysis of the potential for immunosuppression of infants with in-utero and breast milk exposure to antitumor necrosis factor alpha agents: are all agents equally safe? [PDF]

Int J Womens Dermatol
Yaghi M, Dulai AS, Haddad NR, Murase EM, Murase JE.   +4 more
europepmc   +1 more source

Treatment-related mutagenic processes in acute lymphoblastic leukemia. [PDF]

Haematologica
Van der Ham CG, Van Leeuwen FN, Kuiper RP.   +2 more
europepmc   +1 more source